PrEP

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible

Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled […]

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »

Study confirms no transmissions with undetectable HIV

The largest treatment-as-prevention study for gay and bisexual men confirms that people on antiretroviral therapy with undetectable viral load do not transmit HIV. Results from the PARTNER2 study, which enrolled nearly 1,000 mixed-status gay male couples in 14 European countries, saw no genetically linked HIV transmissions when the positive partner was on effective treatment. “PARTNER2

Study confirms no transmissions with undetectable HIV Read More »

One year of preventing new HIV infections throughout B.C.

Thousands of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on Jan. 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see

One year of preventing new HIV infections throughout B.C. Read More »

One year of preventing new HIV infections throughout B.C.

THOUSANDS of people at the highest risk of acquiring HIV in B.C. are benefiting after a successful year since government expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). “Since expanding access to PrEP on January 1, 2018, nearly 3,300 people have been prescribed the potentially life-saving medications. It is positive to see

One year of preventing new HIV infections throughout B.C. Read More »

High levels of unmet PrEP needs among transgender women in Brazil

A study recently published in The Journal of Acquired Immune Deficiency Syndromes indicates that transgender (trans) women in Brazil had low levels of pre-exposure prophylaxis (PrEP) awareness. This was combined with significant proportions being willing to use PrEP as a prevention tool and being eligible for PrEP. Another recent qualitative study published in Culture, Health

High levels of unmet PrEP needs among transgender women in Brazil Read More »